View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
July 27, 2020

ClinX sites ClinEdge and BTC contribute to Covid-19 vaccine programmes

ClinX portfolio companies ClinEdge and BTC Network have announced that more than 20 of ClinX vaccine centres of excellence have been selected for several Covid-19 vaccine programmes.

ClinX portfolio companies ClinEdge and BTC Network have announced that more than 20 of ClinX vaccine centres of excellence have been selected for several Covid-19 vaccine programmes.

Free Report
img

Build resilience in the face of COVID-19 disruption

COVID-19 has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities. Are you interested in actionable insights on the business challenges induced by the pandemic? GlobalData's cross-sector report analyzes the significance of this major disruptive theme across industry verticals. It provides side-by-side research of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ across sectors. Additionally, it offers qualitative analysis of each sector and analyzes COVID-19’s impact on leading companies. Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today.
by GlobalData
Enter your details here to receive your free Report.

These vaccine programmes will start during this summer and winter, according to ClinEdge.

A number of ClinEdge and BTC Network sites are being considered for the upcoming vaccine programmes in preparation for activities related to study start-up.

ClinEdge & BTC president Christian Burns said: “Site selection is critical in any study, but more critical than ever to ensure Covid studies meet historical records of approvals and require vaccine centers of excellence.

“Our dedicated research health and research facilities have proven staff, policies and processes around hybrid study structures in order to achieve enrollment and safety.”

The sites of ClinEdge and BTC Network are in demand during the current Covid-19 crisis because of the significant vaccine experience of the facilities.

Over the past two years, the sites have contributed to around 45 vaccine programmes.

During this Covid-19 pandemic, both networks combined their expertise to launch a new offering with respect to coronavirus-specific vaccine studies.

This offering enables the pharmaceutical and bio-technology firms to have an integrated solution capable of quick track site start-up and enrolment at ClinEdge and BTC Network sites.

Together, the networks provide access to a number of potential volunteers to test experimental vaccines against the novel coronavirus.

All the ClinX network sites have access to ClinEdge and BTCs ‘Risk Mitigation and Recovery Plans’ in order to ensure that the clinical trials are successfully executed as per the FDA guidelines.

In April this year, ClinEdge enhanced its ‘Community Clinical Study Services’ product line, a community-based solution that streamlines the clinical trial process and connects participating sites.

Related Companies

Free Report
img

Build resilience in the face of COVID-19 disruption

COVID-19 has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities. Are you interested in actionable insights on the business challenges induced by the pandemic? GlobalData's cross-sector report analyzes the significance of this major disruptive theme across industry verticals. It provides side-by-side research of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ across sectors. Additionally, it offers qualitative analysis of each sector and analyzes COVID-19’s impact on leading companies. Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena